Borregaard ASA (LON:0QB7)

Market Cap	1.33B -2.1%
Revenue (ttm)	568.49M +1.3%
Net Income	45.70M -24.7%
EPS	0.46 -24.6%
Shares Out	n/a
PE Ratio	29.04
Forward PE	17.31
Dividend	0.30 (0.18%)
Ex-Dividend Date	Apr 11, 2025

Volume	46,272
Average Volume	4,720
Open	173.60
Previous Close	175.00
Day's Range	172.80 - 173.60
52-Week Range	156.05 - 211.50
Beta	0.80
RSI	31.34
Earnings Date	Feb 4, 2026

About Borregaard ASA

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construction, as well as to flavour and fragrance companies, and food and beverage industry. It also develops, produces, and sells speciality cellulose for use ...

• Industry: Chemicals and Allied Products
• Founded: 2012
• Employees: 1,174
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB7

Financial Performance

In 2025, Borregaard ASA's revenue was 7.71 billion, an increase of 1.26% compared to the previous year's 7.62 billion. Earnings were 620.00 million, a decrease of -24.67%.

Financial numbers in NOK